Ellen Klapper
Overview
Explore the profile of Ellen Klapper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobs J, Stanek C, Booth G, Symeonidis A, Shih A, Allen E, et al.
Am J Hematol
. 2024 Aug;
99(11):2063-2074.
PMID: 39136282
Prior studies have suggested that immune thrombotic thrombocytopenic purpura (iTTP) may display seasonal variation; however, methodologic limitations and sample sizes have diminished the ability to perform a rigorous assessment. This...
2.
Jobin P, Stewart C, Vipani A, Perez-Alvarez I, Pepkowitz S, Klapper E, et al.
ACG Case Rep J
. 2024 Mar;
11(3):e01304.
PMID: 38524265
[This corrects the article DOI: 10.14309/crj.0000000000001246.].
3.
Jobin P, Stewart C, Vipani A, Perez-Alvarez I, Pepkowitz S, Klapper E, et al.
ACG Case Rep J
. 2024 Jan;
11(1):e01246.
PMID: 38162005
Mushroom (amatoxin) poisoning from ingestion is a rare but life-threatening medical emergency characterized by gastrointestinal symptoms before progression to multisystem organ failure in severe cases. Many therapies of amatoxin intoxication...
4.
Kozak M, Rubenstein W, Okwan-Duodu D, Friedman K, Nassir Y, Perez-Alvarez I, et al.
Transfusion
. 2023 Apr;
63(6):1241-1245.
PMID: 37096845
Background: There is a small but growing number of thrombotic thrombocytopenic purpura (TTP) cases attributed to immune checkpoint inhibitor therapy, with nivolumab and ipilimumab therapy being the most frequently described...
5.
Cao L, Kim S, Klapper E, Kobashigawa J, Kittleson M
J Clin Med
. 2023 Feb;
12(4).
PMID: 36835873
There are subtypes within blood type A, termed non-A1, that have reduced expression of A antigen on cell surfaces. This can result in the development of anti-A1 antibodies. There is...
6.
Pepkowitz S, Gibb D, Perez-Alvarez I, Phou S, Tanaka J, Rojo J, et al.
Transfusion
. 2022 Oct;
62(10):2153-2154.
PMID: 36214574
No abstract available.
7.
Merin N, LeVee A, Merlo C, Spector K, Coleman H, Klapper E, et al.
Transfus Apher Sci
. 2022 Mar;
61(4):103423.
PMID: 35337753
No abstract available.
8.
Madany E, Lee J, Halprin C, Seo J, Baca N, Majlessipour F, et al.
EJHaem
. 2022 Feb;
2(4):700-710.
PMID: 35128535
Patients with sickle cell disease (SCD) have a high prevalence of RBC alloimmunization. However, underlying mechanisms are poorly understood. Given that proinflammatory type 1 interferons (IFN/) and interferon stimulated genes...
9.
Barnhard S, Klapper E, Kopko P, Tran M, Ziman A
Transfusion
. 2021 Jul;
61(9):2768-2771.
PMID: 34331464
No abstract available.
10.
Hayes C, Rubenstein W, Gibb D, Klapper E, Tanaka J, Pepkowitz S
Transfusion
. 2021 May;
61(8):2245-2249.
PMID: 34036595
Background: COVID-19 convalescent plasma (CCP) is plasma collected from individuals who have recovered from SARS-CoV-2 infection. The FDA Emergency Use Authorization restricts use of CCP to high-titer units only. The...